Form 4 Filing for Phio Pharmaceuticals Corp.

This filing details a transaction by Ronald Todd Plott, a director at Phio Pharmaceuticals Corp. On September 28, 2026, Plott acquired 17,000 shares of common stock with a par value of $.0001. This acquisition was executed at a price of $0.0 per share. Following this transaction, Plott